AnaptysBio, Inc. - Common Stock — Cash Flow (NASDAQ:ANAB) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -14.16 M-45.92 M-73.59 M-120.8 M-135.34 M19.7 M 4.48 M Cash from investing activities 94.47 M38.84 M-394.85 M144.75 M95.4 M228.03 M 248.17 M Cash from financing activities -879 K252.3 M44.02 M-59.3 M127.05 M-132.61 M -102.81 M Free cash flow -14.16 M-45.92 M-73.59 M-120.8 M-135.34 M19.61 M 4.41 M

News

Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year?

Wall Street Analysts See a 38.75% Upside in AnaptysBio (ANAB): Can the Stock Really Move This High?

Forte Biosciences Stock: Targeting Celiac Disease (NASDAQ:FBRX)

AnaptysBio (ANAB) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

RCKT Stock Down on Q1 Earnings Miss, Kresladi Launch in Focus

Why These Four Biotech Stocks Prove That Follow-On Entries Still Pop Up In Stock Market Leaders

Nektar Q1 Earnings & Revenues Lag Estimates, Pipeline in Focus

PBYI Q1 Earnings & Sales Beat Estimates, 2026 Guidance Raised

Zoetis Q1 Earnings Lag Estimates, 2026 View Cut, Stock Down

TGTX Q1 Earnings Miss, Sales Rise Y/Y, Stock Up on Raised 2026 View

Mirum's Q1 Earnings & Revenues Beat Estimates, 2026 View Raised

AnaptysBio, Inc. (ANAB) is a Great Momentum Stock: Should You Buy?